• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Illumina, Inc. - Common Stock (NQ:ILMN)

    214.14 -1.45 (-0.67%)
    Streaming Delayed Price Updated: 11:40 AM EDT, Aug 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Illumina, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    39 40 Next >
    News headline image
    $100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗
    Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.32% on an annualized basis producing an average annual return of 13.55%. Currently, Illumina has a market capitalization... 
    Via Benzinga
    News headline image
    1 Large-Cap Stock with Competitive Advantages and 2 We Find Risky
    Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
    Via StockStory
    News headline image
    Winners And Losers Of Q2: Illumina (NASDAQ:ILMN) Vs The Rest Of The Life Sciences Tools & Services Stocks
    Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Illumina (NASDAQ:ILMN) and... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Precision Medicine Software Market: Companion Diagnostics Rise ↗
    Precision medicine software has moved from a niche research tool to a core piece of modern healthcare infrastructure. As genomic sequencing gets cheaper an 
    Via Talk Markets
    Topics Artificial Intelligence
    Illumina (NASDAQ:ILMN) Beats Q2 Estimates but Shares Slide 6% After-Hours ↗
    Via Chartmill
    Illumina (NASDAQ:ILMN) Scores Perfect Technical Rating and High Setup Quality for Breakout Trade ↗
    Via Chartmill
    News headline image
    1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
    Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
    Via StockStory
    News headline image
    Waters Q2 Earnings Call Highlights ↗
    Waters (NYSE:WAT) reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Biotech AI Retail Solutions Market to Reach USD 7.12 Billion by 2034 ↗
    According to a new report from Intel Market Research, the global Biotech AI Retail Solutions market was valued at USD 3.45 billion in 2025 and is projected 
    Via Talk Markets
    Topics Artificial Intelligence
    News headline image
    5 Must-Read Analyst Questions From Illumina’s Q2 Earnings Call
    Illumina’s second quarter results reflected strong execution in its core clinical sequencing business, with management highlighting robust demand from U.S. a... 
    Via StockStory
    Topics Earnings
    News headline image
    Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗
    Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized basis producing an average annual return of 13.26%. Currently, Illumina has a market capitalization... 
    Via Benzinga
    News headline image
    10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect
    Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results this Thursday after market close. Here’s what to expect. 10x Genomics beat anal... 
    Via StockStory
    News headline image
    PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect
    Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday afternoon. Here’s what you need to know. PacBio mis... 
    Via StockStory
    News headline image
    Illumina (ILMN) Q2 2026 Earnings Call Transcript ↗
    Clinical momentum and NovaSeq X placements drive revenue guidance raise. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    3 Cash-Producing Stocks That Concern Us
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
    Via StockStory
    News headline image
    Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70? ↗
    The developer of blood-based cancer tests still has a bright future. 
    Via The Motley Fool
    News headline image
    Illumina Q2 Earnings Call Highlights ↗
    Illumina (NASDAQ:ILMN) raised its 2026 revenue and earnings outlook after reporting second-quarter results that exceeded its expectations, supported by clinical sequencing demand, elevated NovaSeq X... 
    Via MarketBeat
    Topics Earnings
    News headline image
    ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift
    Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s... 
    Via StockStory
    News headline image
    Illumina (ILMN) Q2 2026 Earnings Call Transcript ↗
    Clinical momentum and NovaSeq X placements drive revenue guidance raise. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Illumina (NASDAQ:ILMN) Surprises With Q2 CY2026 Sales, Full-Year Outlook Slightly Exceeds Expectations
    Genomics company Illumina (NASDAQ:ILMN) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. ... 
    Via StockStory
    News headline image
    Illumina Earnings: What To Look For From ILMN
    Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday after market close. Here’s what to expect. Illumina beat analysts’ ... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    3 Healthcare Stocks with Questionable Fundamentals
    Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron... 
    Via StockStory
    News headline image
    3 Profitable Stocks We Find Risky
    Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
    Via StockStory
    News headline image
    Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. ↗
    The fate of Grail's stock will ultimately be decided in the cost-benefit calculations of medical insurers. 
    Via The Motley Fool
    News headline image
    2 Mooning Stocks Worth Investigating and 1 We Avoid
    Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
    Via StockStory
    News headline image
    Life Sciences Tools & Services Stocks Q1 Results: Benchmarking Illumina (NASDAQ:ILMN)
    Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky
    Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo... 
    Via StockStory
    Topics Energy
    News headline image
    Prediction: Grail Stock Will Skyrocket to $100 in 1 Year ↗
    The cancer test maker still has a bright future. 
    Via The Motley Fool
    News headline image
    3 Mid-Cap Stocks That Concern Us
    Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
    Via StockStory
    News headline image
    Why Illumina (ILMN) Stock Is Down Today
    What Happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 1.9% in the afternoon session after Swiss drugmaker Roche launched a next-generation ge... 
    Via StockStory
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    39 40 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.